Last reviewed · How we verify

NCT04933461

Simulated Clinical Use Testing to Evaluate Sharps Injury Prevention Features of HTL-STREFA's Safety Lancets (Test C)

Completed NA Last updated 21 June 2021
What this trial tests

NA trial testing Safety lancet in Accident Injury in 20 participants. Completed in 27 September 2019.

Timeline
24 September 2019
Primary endpoint
24 September 2019
27 September 2019

Quick facts

Lead sponsorHTL-Strefa S.A.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposeother
Enrollment20
Start date24 September 2019
Primary completion24 September 2019
Estimated completion27 September 2019
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

HTL-Strefa S.A.

Who can join

18 and older, any sex, with Accident Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A simulated clinical use testing to evaluate the Medlance Plus and myLance sharps injury prevention feature in accordance with the FDA's guidance on medical devices with sharps injury prevention features.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other HTL-Strefa S.A. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04933461.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing